Summary
93 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 34 USD is left as net profit.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $9.80B in the last fiscal year, 26% of its market value.
- Earnings per share grew by 10% a year over the last 3 years.
What to watch
- Revenue growth is slowing: 7.5% a year over the last 3 years against 18% over 5 years.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapPrice against the Bulios Fair Price
P/E against its own last 5 years
P/E against the industry (Financial - Capital Markets)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 3.7 USD for 1 USD of yearly profit. Over the last five years it was 7.3 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 18% a year over 5 years. Over the last 3 years it grew by 7.5% a year. For the next fiscal year analysts expect revenue to grow by 2.1%. Earnings per share grew by 10% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 13 USD
- Sales and administration 43 USD
- Taxes and other 9.9 USD
- Net profit 34 USD
Net profit, industry median (Financial - Capital Markets) 1.0 USD
Out of every 100 USD of revenue, 34 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, safe- Yield
- 7.05%
- Paid out of profit
- 26%
You receive $1.49 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 21
- Hold 7
- Sell 3
No analyst has published a price target.
68% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Investor Services 79%
- Advisor Services 21%
By region
The company reports no revenue by region.
Investor Services brings in 79% of revenue.
Segments in detail